Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 30)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
8-Feb-10Market EdgeN/AMarket Edge Equity Research Report4$10  View Abstract
8-Feb-10PriceTarget Research, Inc.N/AAtricure has a current Overall Rating of C (Neutral).7$25  View Abstract
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: ATRICURE -- ATRC1$4  View Abstract
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: ATRC , CUTR , ELRNF , HDIX , IRIX , SLTM , ELOS -- MEDICAL SUPPLIES & EQUIPMENT3$4  View Abstract
4-Feb-10Wright ReportsN/AWright Investors Service Comprehensive Report for Atricure, Inc.40$65  View Abstract
2-Feb-10EconomicInvestorN/A"The Economy Matters" Report for ATRC: the economy's impact on ATRC's price and risk, featuring the powerful EconomicInvestor Star Rating6$15  View Abstract
31-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ATRICURE INC5$25  View Abstract
26-Jan-10Roth Capital Partners, Inc.Research DepartmentMorning Call Summary11$25  View Abstract
25-Jan-10Roth Capital Partners, Inc.Matt Dolan4Q09 Medical Device Earnings Preview: Part 16$254 Stars  View Abstract
24-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ATRICURE INC5$25  View Abstract
Next 20

Brokerage Reports (Showing 1 to 5 of 5)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
26-Jan-10Roth Capital Partners, Inc.Research DepartmentMorning Call Summary11$25  View Abstract
25-Jan-10Roth Capital Partners, Inc.Matt Dolan4Q09 Medical Device Earnings Preview: Part 16$254 Stars  View Abstract
7-Jan-10Duncan-Williams, IncJames TerwilligerInitiation of Coverage With a BUY Rating22$75  View Abstract
6-Jan-10Roth Capital Partners, Inc.Matt Dolan4Q 2009: Quarterly Medical Device Trading & Acquisition Valuation Update8$254 Stars  View Abstract
6-Jan-10Roth Capital Partners, Inc.Research DepartmentMorning Call Summary14$50  View Abstract

Independent Reports (Showing 1 to 10 of 25)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
8-Feb-10Market EdgeN/AMarket Edge Equity Research Report4$10View Abstract
8-Feb-10PriceTarget Research, Inc.N/AAtricure has a current Overall Rating of C (Neutral).7$25View Abstract
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: ATRICURE -- ATRC1$4View Abstract
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: ATRC , CUTR , ELRNF , HDIX , IRIX , SLTM , ELOS -- MEDICAL SUPPLIES & EQUIPMENT3$4View Abstract
4-Feb-10Wright ReportsN/AWright Investors Service Comprehensive Report for Atricure, Inc.40$65View Abstract
2-Feb-10EconomicInvestorN/A"The Economy Matters" Report for ATRC: the economy's impact on ATRC's price and risk, featuring the powerful EconomicInvestor Star Rating6$15View Abstract
31-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ATRICURE INC5$25View Abstract
24-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ATRICURE INC5$25View Abstract
18-Jan-10Zacks Investment Research Inc.N/AATRICURE INC (ATRC) Zacks Company Snapshot1$10View Abstract
17-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ATRICURE INC5$25View Abstract
Next 15

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.